Cargando…
IgY antibodies for the immunoprophylaxis and therapy of respiratory infections
Emergence of drug resistance among the causative organisms for respiratory tract infections represents a critical challenge to the global health care community. Further, although vaccination can prevent disease, vaccine development is impeded by several factors. Therefore, novel approaches to treat...
Autores principales: | Abbas, Aymn Talat, El-Kafrawy, Sherif Aly, Sohrab, Sayed Sartaj, Azhar, Esam Ibraheem Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363154/ https://www.ncbi.nlm.nih.gov/pubmed/30230944 http://dx.doi.org/10.1080/21645515.2018.1514224 |
Ejemplares similares
-
Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model
por: Abbas, Aymn T., et al.
Publicado: (2020) -
IgY antibodies: The promising potential to overcome antibiotic resistance
por: El-Kafrawy, Sherif A., et al.
Publicado: (2023) -
Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection
por: El-Kafrawy, Sherif A., et al.
Publicado: (2021) -
In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells
por: Sartaj Sohrab, Sayed, et al.
Publicado: (2022) -
Effect of insilico predicted and designed potential siRNAs on inhibition of SARS-CoV-2 in HEK-293 cells
por: Sohrab, Sayed Sartaj, et al.
Publicado: (2022)